0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Invited Commentary | 
Eric K. Nakakura, MD, PhD
JAMA Surg. 2014;149(5):466. doi:10.1001/jamasurg.2013.5282.

Original Investigation | 
Raymond F. Lamore III, PharmD; Elizabeth M. Hechenbleikner, MD; Christina Ha, MD; et al.
JAMA Surg. 2014;149(5):459-466. doi:10.1001/jamasurg.2013.5278.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Psychiatry
Editorial  | 
Why Are Benzodiazepines Not Yet Controlled Substances?
Nicholas Moore, MD, PhD; Antoine Pariente, MD, PhD; Bernard Bégaud, MD, PhD
JAMA Psychiatry
Original Investigation  | 
Benzodiazepine Use in the United States
Mark Olfson, MD, MPH; Marissa King, PhD; Michael Schoenbaum, PhD
JAMA Internal Medicine
Research Letter  | 
Effect of Public Disclosure on Antibiotic Prescription Rate for Upper Respiratory Tract Infections
Jae Moon Yun, MPH; Dong Wook Shin, MD, DrPH, MBA; Seung-sik Hwang, MD, PhD; et al.
JAMA Internal Medicine
Invited Commentary  | 
Tramadol and Hypoglycemia:  One More Thing to Worry About
Lewis S. Nelson, MD; David N. Juurlink, MD, PhD